No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
COMP240517C4000
- 0.25
- +0.10+66.67%
15min DelayTrading May 14 12:57 ET
0.40High0.25Low
0.25Open0.15Pre Close98 Volume2.01K Open Interest4.00Strike Price3.37KTurnover0.00%IV-0.23%PremiumMay 17, 2024Expiry Date0.26Intrinsic Value100Multiplier3DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma17.04Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Ex-Google Chief Eric Schmidt Finds Buyer Two Weeks After Listing Silicon Valley Home -- WSJ
By E.B. Solomont Be the first to know about the biggest and best luxury home sales and listings by signing up for our Mansion Deals email alert. Former Google CEO Eric Schmidt and his wife, Wendy S
In-Depth Examination Of 10 Analyst Recommendations For Compass
In the preceding three months, 10 analysts have released ratings for Compass (NYSE:COMP), presenting a wide array of perspectives from bullish to bearish.Summarizing their recent assessments, the tabl
Express News | HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $10 Price Target
Compass Is Maintained at Neutral by UBS
Compass Is Maintained at Neutral by UBS
Express News | UBS Maintains Neutral on Compass, Raises Price Target to $4
Compass Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 -7.83% UBS $3.5 → $4 Maintains Neutral 05/09/2024 15.21% Needham → $5 Reiterates Buy → Buy 03/0
Comments
Investors may have concerns about the financial implications of the settlement, despite it not anticipated to impact Compass' ability to serve its clients.
Compass Settles Suit on Commissions. The Real Estate Brokerage's Stock Is Down. -- Barrons.com 1
Analysts are confident in Compass' growth, expecting an 83% annual rate. The company's low debt reduces investment risk. However, if growth rate is overly optimistic, profitability could be delayed.
1
Compass Lexecon's leadership changes are viewed as a team enhancement, with new leaders anticipated to propel the business and deliver superior client service. These changes are also predicted to bolster the company's growth across the EMEA region via new market penetration, expanded services, and talent growth.
Despite its liabilities, Compass has net cash, indicating a light debt load. However, its future profitability will determine its balance sheet strength. The company appears risky due to lack of free cash flow and recent pre-tax loss.
1
CEO Elias Sabo is optimistic about more consumer-focused acquisitions in 2024, finding the sector's deals attractive. Compass aims to include healthcare in its portfolio. Despite high net debt, Sabo is comfortable with the company's position due to anticipated rapid growth.
Read more